Results 81 to 90 of about 13,172 (206)
Evaluation of the Efficacy of Budesonide Combined with Pulmonary Surfactants on the Neonatal Respiratory Distress Syndrome by Pulmonary Ultrasonography [PDF]
Chuanlong Zhang
openalex +1 more source
Advances in nanotechnology for the therapy of bacterial pneumonia
Bacterial pneumonia, a life-threatening infection, is the world’s sixth deadliest disease and the top cause of mortality in children under five. Without timely treatment, bacterial pneumonia can escalate to a 30% mortality rate, particularly in high-risk
Zihan Tian +6 more
doaj +1 more source
Background: In recent years, various noninvasive respiratory support (NRS) of ventilation has been provided more in neonates. The aim of this study was to compare the effect of HFNC with NCPAP in post-extubation of preterm infants with RDS after INSURE ...
Maliheh Kadivar +4 more
doaj
Erratum to: “Surfactant protein a polymorphism is associated with susceptibility to chronic obstructive pulmonary disease in Chinese uighur population” [PDF]
Jian Guan
openalex +1 more source
Inhibition of Pulmonary Surfactants Synthesis during N‐Methyl‐
Li Shen +5 more
openalex +1 more source
Surfactant replacement therapy is now an integral part of the care of neonates since several clinical trials of natural surfactant extracts and synthetic preparations have shown efficacy in the treatment of infants with hyaline membrane disease.
F R, Poulain, J A, Clements
openaire +1 more source
Inhibition of Daptomycin by Pulmonary Surfactant: In Vitro Modeling and Clinical Impact [PDF]
Jared Silverman +4 more
openalex +1 more source

